A patient with refractory high-grade B-cell lymphoma and rapid progression under CAR-T-cell therapy was successfully salvaged with inotuzumab- ozogamicinT. Strüßmann, R. Wäsch, F. Scherer,J. A. Mutter, D. Pfeifer, I. Bartsch, S. Giesler, G. Graziani, J. Duyster,J. Finke, R. MarksLeukemia & lymphoma（2022）引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
